医疗营养治疗和体育炼治疗急性和慢性高血糖患者与沙科佩尼亚
Ángel Luis Abad-González1,2, Silvia Veses3, María Argente Pla4
1Endocrinology and Nutrition Department, Hospital General Universitario Dr. Balmis, 03010 Alicante, Spain.
Nutrients
|February 13, 2025
概括
过高血糖症和缩症相互恶化. 功能营养素和体育活动可以改善肌肉状况和血糖控制在受影响的患者.
科学领域:
- 老年学是一门学科.
- 代谢过程中的代谢.
- 运动生理学 运动生理学
背景情况:
- 高血糖 (高血糖) 和肉 (与年龄相关的肌肉损失) 经常同时存在,导致身体功能差,生活质量降低,死亡率增加.
- 营养不良和身体不活动是导致高血糖和肉类的不良结果的关键因素.
- 这些情况在一个有害的循环中相互关联,其中每一个都会加剧另一个.
研究的目的:
- 审查高血糖症对肌肉和运动功能的影响,重点关注潜在的生化机制.
- 突出评估和管理高血糖个体中的临床重要性.
- 评估营养治疗和体育活动作为治疗肌肉健康的潜力.
主要方法:
- 对高血糖症,肉症及其相互作用的证据的文献综述.
- 分析与糖尿病和肉类相关的肌肉中的生化变化.
- 评估临床管理策略,包括营养和运动.
主要成果:
- 高血糖症通过特定的生化途径对肌肉和运动功能产生负面影响.
- 对高血糖患者来说,临床评估和治疗缩症至关重要.
- 医学营养治疗和体育活动对改善肌肉状况有希望.
结论:
- 功能性营养素和结构化的体力活动对于管理高血糖症和肉症至关重要.
- 结合营养和运动干预措施可以改善血糖和肌肉健康.
- 这些策略为患有这两种疾病的人提供了一条通往更好的结果的途径.
相关概念视频
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
55
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
55
Oral Hypoglycemic Agents: Biguanides and Glitazones
160
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
160
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Insulin: Dosing Regimen and Adverse Effects
140
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
140


